nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—Lomustine—hematologic cancer	0.0437	0.0738	CbGbCtD
Hydrocodone—CYP2D6—Idarubicin—hematologic cancer	0.039	0.0658	CbGbCtD
Hydrocodone—CYP2D6—Hydroxyurea—hematologic cancer	0.0331	0.0559	CbGbCtD
Hydrocodone—CYP3A4—Bexarotene—hematologic cancer	0.0299	0.0505	CbGbCtD
Hydrocodone—CYP2D6—Bortezomib—hematologic cancer	0.0288	0.0487	CbGbCtD
Hydrocodone—CYP3A4—Busulfan—hematologic cancer	0.0278	0.0469	CbGbCtD
Hydrocodone—CYP3A4—Lomustine—hematologic cancer	0.0278	0.0469	CbGbCtD
Hydrocodone—CYP3A4—Thiotepa—hematologic cancer	0.0248	0.0418	CbGbCtD
Hydrocodone—CYP2D6—Imatinib—hematologic cancer	0.0211	0.0356	CbGbCtD
Hydrocodone—CYP3A4—Methoxsalen—hematologic cancer	0.0193	0.0325	CbGbCtD
Hydrocodone—CYP2D6—Nilotinib—hematologic cancer	0.0192	0.0324	CbGbCtD
Hydrocodone—CYP2D6—Vinorelbine—hematologic cancer	0.019	0.0321	CbGbCtD
Hydrocodone—CYP3A4—Bortezomib—hematologic cancer	0.0183	0.0309	CbGbCtD
Hydrocodone—CYP3A4—Daunorubicin—hematologic cancer	0.0175	0.0296	CbGbCtD
Hydrocodone—CYP3A4—Cytarabine—hematologic cancer	0.0155	0.0261	CbGbCtD
Hydrocodone—CYP3A4—Teniposide—hematologic cancer	0.0152	0.0257	CbGbCtD
Hydrocodone—CYP3A4—Ifosfamide—hematologic cancer	0.0141	0.0237	CbGbCtD
Hydrocodone—CYP3A4—Imatinib—hematologic cancer	0.0134	0.0227	CbGbCtD
Hydrocodone—CYP3A4—Ruxolitinib—hematologic cancer	0.0126	0.0213	CbGbCtD
Hydrocodone—CYP3A4—Nilotinib—hematologic cancer	0.0122	0.0206	CbGbCtD
Hydrocodone—CYP3A4—Vinorelbine—hematologic cancer	0.0121	0.0204	CbGbCtD
Hydrocodone—CYP2D6—Vinblastine—hematologic cancer	0.0117	0.0198	CbGbCtD
Hydrocodone—CYP3A4—Triamcinolone—hematologic cancer	0.0111	0.0187	CbGbCtD
Hydrocodone—CYP3A4—Dasatinib—hematologic cancer	0.0108	0.0182	CbGbCtD
Hydrocodone—CYP3A4—Mitoxantrone—hematologic cancer	0.0107	0.018	CbGbCtD
Hydrocodone—CYP3A4—Betamethasone—hematologic cancer	0.00949	0.016	CbGbCtD
Hydrocodone—CYP3A4—Prednisolone—hematologic cancer	0.00937	0.0158	CbGbCtD
Hydrocodone—CYP3A4—Prednisone—hematologic cancer	0.00885	0.0149	CbGbCtD
Hydrocodone—CYP2D6—Dexamethasone—hematologic cancer	0.00868	0.0147	CbGbCtD
Hydrocodone—CYP3A4—Irinotecan—hematologic cancer	0.00839	0.0142	CbGbCtD
Hydrocodone—CYP3A4—Vinblastine—hematologic cancer	0.00746	0.0126	CbGbCtD
Hydrocodone—CYP3A4—Vincristine—hematologic cancer	0.00733	0.0124	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—hematologic cancer	0.0072	0.0122	CbGbCtD
Hydrocodone—CYP3A4—Etoposide—hematologic cancer	0.00672	0.0113	CbGbCtD
Hydrocodone—CYP3A4—Dexamethasone—hematologic cancer	0.00552	0.00932	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—hematologic cancer	0.00458	0.00773	CbGbCtD
Hydrocodone—Naloxone—CREB1—hematologic cancer	0.00192	0.373	CrCbGaD
Hydrocodone—Naltrexone—UGT1A1—hematologic cancer	0.000929	0.18	CrCbGaD
Hydrocodone—Morphine—UGT1A1—hematologic cancer	0.000572	0.111	CrCbGaD
Hydrocodone—Codeine—SLC22A1—hematologic cancer	0.000569	0.11	CrCbGaD
Hydrocodone—Naloxone—ESR1—hematologic cancer	0.000373	0.0725	CrCbGaD
Hydrocodone—Naltrexone—ABCB1—hematologic cancer	0.000217	0.0422	CrCbGaD
Hydrocodone—Naloxone—ALB—hematologic cancer	0.000166	0.0323	CrCbGaD
Hydrocodone—Naloxone—ABCB1—hematologic cancer	0.000159	0.0308	CrCbGaD
Hydrocodone—Morphine—ABCB1—hematologic cancer	0.000134	0.026	CrCbGaD
Hydrocodone—Dextromethorphan—ABCB1—hematologic cancer	0.000112	0.0218	CrCbGaD
Hydrocodone—Paraesthesia—Triamcinolone—hematologic cancer	8.38e-05	0.000256	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—hematologic cancer	8.37e-05	0.000256	CcSEcCtD
Hydrocodone—Headache—Carmustine—hematologic cancer	8.33e-05	0.000255	CcSEcCtD
Hydrocodone—Dyspnoea—Triamcinolone—hematologic cancer	8.32e-05	0.000254	CcSEcCtD
Hydrocodone—Rash—Alitretinoin—hematologic cancer	8.31e-05	0.000254	CcSEcCtD
Hydrocodone—Nervous system disorder—Betamethasone—hematologic cancer	8.3e-05	0.000254	CcSEcCtD
Hydrocodone—Nervous system disorder—Dexamethasone—hematologic cancer	8.3e-05	0.000254	CcSEcCtD
Hydrocodone—Dermatitis—Alitretinoin—hematologic cancer	8.3e-05	0.000254	CcSEcCtD
Hydrocodone—Thrombocytopenia—Betamethasone—hematologic cancer	8.29e-05	0.000253	CcSEcCtD
Hydrocodone—Thrombocytopenia—Dexamethasone—hematologic cancer	8.29e-05	0.000253	CcSEcCtD
Hydrocodone—Vomiting—Ifosfamide—hematologic cancer	8.28e-05	0.000253	CcSEcCtD
Hydrocodone—Hypersensitivity—Cisplatin—hematologic cancer	8.27e-05	0.000253	CcSEcCtD
Hydrocodone—Headache—Alitretinoin—hematologic cancer	8.26e-05	0.000252	CcSEcCtD
Hydrocodone—Nausea—Thalidomide—hematologic cancer	8.23e-05	0.000251	CcSEcCtD
Hydrocodone—Rash—Ifosfamide—hematologic cancer	8.21e-05	0.000251	CcSEcCtD
Hydrocodone—Dermatitis—Ifosfamide—hematologic cancer	8.21e-05	0.000251	CcSEcCtD
Hydrocodone—Hyperhidrosis—Betamethasone—hematologic cancer	8.19e-05	0.00025	CcSEcCtD
Hydrocodone—Hyperhidrosis—Dexamethasone—hematologic cancer	8.19e-05	0.00025	CcSEcCtD
Hydrocodone—Dizziness—Irinotecan—hematologic cancer	8.18e-05	0.00025	CcSEcCtD
Hydrocodone—Abdominal pain—Etoposide—hematologic cancer	8.13e-05	0.000248	CcSEcCtD
Hydrocodone—Body temperature increased—Etoposide—hematologic cancer	8.13e-05	0.000248	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—hematologic cancer	8.13e-05	0.000248	CcSEcCtD
Hydrocodone—Vomiting—Vincristine—hematologic cancer	8.08e-05	0.000247	CcSEcCtD
Hydrocodone—Asthenia—Cisplatin—hematologic cancer	8.06e-05	0.000246	CcSEcCtD
Hydrocodone—Fatigue—Triamcinolone—hematologic cancer	8.05e-05	0.000246	CcSEcCtD
Hydrocodone—Rash—Vincristine—hematologic cancer	8.01e-05	0.000245	CcSEcCtD
Hydrocodone—Dermatitis—Vincristine—hematologic cancer	8e-05	0.000244	CcSEcCtD
Hydrocodone—Oedema peripheral—Epirubicin—hematologic cancer	8e-05	0.000244	CcSEcCtD
Hydrocodone—Connective tissue disorder—Epirubicin—hematologic cancer	7.98e-05	0.000244	CcSEcCtD
Hydrocodone—Headache—Vincristine—hematologic cancer	7.96e-05	0.000243	CcSEcCtD
Hydrocodone—Hypotension—Dexamethasone—hematologic cancer	7.91e-05	0.000242	CcSEcCtD
Hydrocodone—Hypotension—Betamethasone—hematologic cancer	7.91e-05	0.000242	CcSEcCtD
Hydrocodone—Nausea—Carmustine—hematologic cancer	7.9e-05	0.000241	CcSEcCtD
Hydrocodone—Angiopathy—Methotrexate—hematologic cancer	7.87e-05	0.00024	CcSEcCtD
Hydrocodone—Vomiting—Irinotecan—hematologic cancer	7.86e-05	0.00024	CcSEcCtD
Hydrocodone—Vomiting—Mitoxantrone—hematologic cancer	7.86e-05	0.00024	CcSEcCtD
Hydrocodone—Nausea—Alitretinoin—hematologic cancer	7.83e-05	0.000239	CcSEcCtD
Hydrocodone—Convulsion—Prednisone—hematologic cancer	7.83e-05	0.000239	CcSEcCtD
Hydrocodone—Mediastinal disorder—Methotrexate—hematologic cancer	7.82e-05	0.000239	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—hematologic cancer	7.81e-05	0.000239	CcSEcCtD
Hydrocodone—Rash—Irinotecan—hematologic cancer	7.8e-05	0.000238	CcSEcCtD
Hydrocodone—Rash—Mitoxantrone—hematologic cancer	7.8e-05	0.000238	CcSEcCtD
Hydrocodone—Dermatitis—Mitoxantrone—hematologic cancer	7.79e-05	0.000238	CcSEcCtD
Hydrocodone—Dermatitis—Irinotecan—hematologic cancer	7.79e-05	0.000238	CcSEcCtD
Hydrocodone—Headache—Mitoxantrone—hematologic cancer	7.75e-05	0.000237	CcSEcCtD
Hydrocodone—Headache—Irinotecan—hematologic cancer	7.75e-05	0.000237	CcSEcCtD
Hydrocodone—Nausea—Ifosfamide—hematologic cancer	7.74e-05	0.000236	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	7.71e-05	0.000236	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	7.71e-05	0.000236	CcSEcCtD
Hydrocodone—Arthralgia—Prednisone—hematologic cancer	7.69e-05	0.000235	CcSEcCtD
Hydrocodone—Myalgia—Prednisone—hematologic cancer	7.69e-05	0.000235	CcSEcCtD
Hydrocodone—Anxiety—Prednisone—hematologic cancer	7.67e-05	0.000234	CcSEcCtD
Hydrocodone—Vomiting—Gemcitabine—hematologic cancer	7.66e-05	0.000234	CcSEcCtD
Hydrocodone—Insomnia—Dexamethasone—hematologic cancer	7.66e-05	0.000234	CcSEcCtD
Hydrocodone—Insomnia—Betamethasone—hematologic cancer	7.66e-05	0.000234	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	7.64e-05	0.000233	CcSEcCtD
Hydrocodone—Paraesthesia—Betamethasone—hematologic cancer	7.6e-05	0.000232	CcSEcCtD
Hydrocodone—Paraesthesia—Dexamethasone—hematologic cancer	7.6e-05	0.000232	CcSEcCtD
Hydrocodone—Mental disorder—Methotrexate—hematologic cancer	7.6e-05	0.000232	CcSEcCtD
Hydrocodone—Rash—Gemcitabine—hematologic cancer	7.6e-05	0.000232	CcSEcCtD
Hydrocodone—Dermatitis—Gemcitabine—hematologic cancer	7.59e-05	0.000232	CcSEcCtD
Hydrocodone—Hypersensitivity—Etoposide—hematologic cancer	7.58e-05	0.000232	CcSEcCtD
Hydrocodone—Malnutrition—Methotrexate—hematologic cancer	7.55e-05	0.000231	CcSEcCtD
Hydrocodone—Headache—Gemcitabine—hematologic cancer	7.55e-05	0.000231	CcSEcCtD
Hydrocodone—Nausea—Vincristine—hematologic cancer	7.54e-05	0.00023	CcSEcCtD
Hydrocodone—Hypersensitivity—Prednisolone—hematologic cancer	7.48e-05	0.000228	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—hematologic cancer	7.4e-05	0.000226	CcSEcCtD
Hydrocodone—Asthenia—Etoposide—hematologic cancer	7.38e-05	0.000226	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—hematologic cancer	7.38e-05	0.000225	CcSEcCtD
Hydrocodone—Body temperature increased—Triamcinolone—hematologic cancer	7.38e-05	0.000225	CcSEcCtD
Hydrocodone—Angiopathy—Epirubicin—hematologic cancer	7.36e-05	0.000225	CcSEcCtD
Hydrocodone—Nausea—Irinotecan—hematologic cancer	7.35e-05	0.000224	CcSEcCtD
Hydrocodone—Nausea—Mitoxantrone—hematologic cancer	7.35e-05	0.000224	CcSEcCtD
Hydrocodone—Mediastinal disorder—Epirubicin—hematologic cancer	7.32e-05	0.000223	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Betamethasone—hematologic cancer	7.31e-05	0.000223	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	7.31e-05	0.000223	CcSEcCtD
Hydrocodone—Back pain—Methotrexate—hematologic cancer	7.3e-05	0.000223	CcSEcCtD
Hydrocodone—Fatigue—Dexamethasone—hematologic cancer	7.3e-05	0.000223	CcSEcCtD
Hydrocodone—Fatigue—Betamethasone—hematologic cancer	7.3e-05	0.000223	CcSEcCtD
Hydrocodone—Pruritus—Etoposide—hematologic cancer	7.28e-05	0.000222	CcSEcCtD
Hydrocodone—Nervous system disorder—Prednisone—hematologic cancer	7.23e-05	0.000221	CcSEcCtD
Hydrocodone—Skin disorder—Prednisone—hematologic cancer	7.16e-05	0.000219	CcSEcCtD
Hydrocodone—Nausea—Gemcitabine—hematologic cancer	7.16e-05	0.000219	CcSEcCtD
Hydrocodone—Vomiting—Cisplatin—hematologic cancer	7.14e-05	0.000218	CcSEcCtD
Hydrocodone—Hyperhidrosis—Prednisone—hematologic cancer	7.13e-05	0.000218	CcSEcCtD
Hydrocodone—Mental disorder—Epirubicin—hematologic cancer	7.11e-05	0.000217	CcSEcCtD
Hydrocodone—Rash—Cisplatin—hematologic cancer	7.08e-05	0.000216	CcSEcCtD
Hydrocodone—Dermatitis—Cisplatin—hematologic cancer	7.07e-05	0.000216	CcSEcCtD
Hydrocodone—Malnutrition—Epirubicin—hematologic cancer	7.07e-05	0.000216	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Dexamethasone—hematologic cancer	6.92e-05	0.000212	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Betamethasone—hematologic cancer	6.92e-05	0.000212	CcSEcCtD
Hydrocodone—Hypersensitivity—Triamcinolone—hematologic cancer	6.88e-05	0.00021	CcSEcCtD
Hydrocodone—Back pain—Epirubicin—hematologic cancer	6.84e-05	0.000209	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—hematologic cancer	6.81e-05	0.000208	CcSEcCtD
Hydrocodone—Dizziness—Etoposide—hematologic cancer	6.8e-05	0.000208	CcSEcCtD
Hydrocodone—Muscle spasms—Epirubicin—hematologic cancer	6.79e-05	0.000208	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—hematologic cancer	6.77e-05	0.000207	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.72e-05	0.000205	CcSEcCtD
Hydrocodone—Dizziness—Prednisolone—hematologic cancer	6.71e-05	0.000205	CcSEcCtD
Hydrocodone—Asthenia—Triamcinolone—hematologic cancer	6.7e-05	0.000205	CcSEcCtD
Hydrocodone—Abdominal pain—Dexamethasone—hematologic cancer	6.69e-05	0.000204	CcSEcCtD
Hydrocodone—Body temperature increased—Betamethasone—hematologic cancer	6.69e-05	0.000204	CcSEcCtD
Hydrocodone—Body temperature increased—Dexamethasone—hematologic cancer	6.69e-05	0.000204	CcSEcCtD
Hydrocodone—Abdominal pain—Betamethasone—hematologic cancer	6.69e-05	0.000204	CcSEcCtD
Hydrocodone—Nausea—Cisplatin—hematologic cancer	6.67e-05	0.000204	CcSEcCtD
Hydrocodone—Insomnia—Prednisone—hematologic cancer	6.67e-05	0.000204	CcSEcCtD
Hydrocodone—Paraesthesia—Prednisone—hematologic cancer	6.62e-05	0.000202	CcSEcCtD
Hydrocodone—Pruritus—Triamcinolone—hematologic cancer	6.6e-05	0.000202	CcSEcCtD
Hydrocodone—Cough—Methotrexate—hematologic cancer	6.59e-05	0.000201	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—hematologic cancer	6.58e-05	0.000201	CcSEcCtD
Hydrocodone—Convulsion—Methotrexate—hematologic cancer	6.54e-05	0.0002	CcSEcCtD
Hydrocodone—Vomiting—Etoposide—hematologic cancer	6.54e-05	0.0002	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—hematologic cancer	6.54e-05	0.0002	CcSEcCtD
Hydrocodone—Rash—Etoposide—hematologic cancer	6.49e-05	0.000198	CcSEcCtD
Hydrocodone—Dermatitis—Etoposide—hematologic cancer	6.48e-05	0.000198	CcSEcCtD
Hydrocodone—Headache—Etoposide—hematologic cancer	6.45e-05	0.000197	CcSEcCtD
Hydrocodone—Myalgia—Methotrexate—hematologic cancer	6.43e-05	0.000196	CcSEcCtD
Hydrocodone—Arthralgia—Methotrexate—hematologic cancer	6.43e-05	0.000196	CcSEcCtD
Hydrocodone—Rash—Prednisolone—hematologic cancer	6.4e-05	0.000195	CcSEcCtD
Hydrocodone—Dermatitis—Prednisolone—hematologic cancer	6.39e-05	0.000195	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	6.38e-05	0.000195	CcSEcCtD
Hydrocodone—Fatigue—Prednisone—hematologic cancer	6.36e-05	0.000194	CcSEcCtD
Hydrocodone—Headache—Prednisolone—hematologic cancer	6.36e-05	0.000194	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—hematologic cancer	6.32e-05	0.000193	CcSEcCtD
Hydrocodone—Constipation—Prednisone—hematologic cancer	6.31e-05	0.000193	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—hematologic cancer	6.29e-05	0.000192	CcSEcCtD
Hydrocodone—Dizziness—Triamcinolone—hematologic cancer	6.17e-05	0.000189	CcSEcCtD
Hydrocodone—Cough—Epirubicin—hematologic cancer	6.17e-05	0.000188	CcSEcCtD
Hydrocodone—Convulsion—Epirubicin—hematologic cancer	6.12e-05	0.000187	CcSEcCtD
Hydrocodone—Nausea—Etoposide—hematologic cancer	6.11e-05	0.000187	CcSEcCtD
Hydrocodone—Asthenia—Dexamethasone—hematologic cancer	6.07e-05	0.000186	CcSEcCtD
Hydrocodone—Asthenia—Betamethasone—hematologic cancer	6.07e-05	0.000186	CcSEcCtD
Hydrocodone—Nervous system disorder—Methotrexate—hematologic cancer	6.04e-05	0.000185	CcSEcCtD
Hydrocodone—Thrombocytopenia—Methotrexate—hematologic cancer	6.03e-05	0.000184	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Prednisone—hematologic cancer	6.03e-05	0.000184	CcSEcCtD
Hydrocodone—Nausea—Prednisolone—hematologic cancer	6.03e-05	0.000184	CcSEcCtD
Hydrocodone—Arthralgia—Epirubicin—hematologic cancer	6.02e-05	0.000184	CcSEcCtD
Hydrocodone—Myalgia—Epirubicin—hematologic cancer	6.02e-05	0.000184	CcSEcCtD
Hydrocodone—Anxiety—Epirubicin—hematologic cancer	6e-05	0.000183	CcSEcCtD
Hydrocodone—Pruritus—Dexamethasone—hematologic cancer	5.99e-05	0.000183	CcSEcCtD
Hydrocodone—Pruritus—Betamethasone—hematologic cancer	5.99e-05	0.000183	CcSEcCtD
Hydrocodone—Skin disorder—Methotrexate—hematologic cancer	5.99e-05	0.000183	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.97e-05	0.000183	CcSEcCtD
Hydrocodone—Hyperhidrosis—Methotrexate—hematologic cancer	5.96e-05	0.000182	CcSEcCtD
Hydrocodone—Vomiting—Triamcinolone—hematologic cancer	5.93e-05	0.000181	CcSEcCtD
Hydrocodone—Rash—Triamcinolone—hematologic cancer	5.88e-05	0.00018	CcSEcCtD
Hydrocodone—Dry mouth—Epirubicin—hematologic cancer	5.88e-05	0.00018	CcSEcCtD
Hydrocodone—Dermatitis—Triamcinolone—hematologic cancer	5.88e-05	0.00018	CcSEcCtD
Hydrocodone—Headache—Triamcinolone—hematologic cancer	5.85e-05	0.000179	CcSEcCtD
Hydrocodone—Abdominal pain—Prednisone—hematologic cancer	5.83e-05	0.000178	CcSEcCtD
Hydrocodone—Body temperature increased—Prednisone—hematologic cancer	5.83e-05	0.000178	CcSEcCtD
Hydrocodone—Hypotension—Methotrexate—hematologic cancer	5.76e-05	0.000176	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—hematologic cancer	5.71e-05	0.000174	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—hematologic cancer	5.66e-05	0.000173	CcSEcCtD
Hydrocodone—Nervous system disorder—Epirubicin—hematologic cancer	5.66e-05	0.000173	CcSEcCtD
Hydrocodone—Thrombocytopenia—Epirubicin—hematologic cancer	5.65e-05	0.000173	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.61e-05	0.000172	CcSEcCtD
Hydrocodone—Skin disorder—Epirubicin—hematologic cancer	5.6e-05	0.000171	CcSEcCtD
Hydrocodone—Dizziness—Betamethasone—hematologic cancer	5.6e-05	0.000171	CcSEcCtD
Hydrocodone—Dizziness—Dexamethasone—hematologic cancer	5.6e-05	0.000171	CcSEcCtD
Hydrocodone—Hyperhidrosis—Epirubicin—hematologic cancer	5.58e-05	0.00017	CcSEcCtD
Hydrocodone—Insomnia—Methotrexate—hematologic cancer	5.57e-05	0.00017	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—hematologic cancer	5.57e-05	0.00017	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—hematologic cancer	5.57e-05	0.00017	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—hematologic cancer	5.55e-05	0.000169	CcSEcCtD
Hydrocodone—Nausea—Triamcinolone—hematologic cancer	5.54e-05	0.000169	CcSEcCtD
Hydrocodone—Paraesthesia—Methotrexate—hematologic cancer	5.53e-05	0.000169	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.53e-05	0.000169	CcSEcCtD
Hydrocodone—Dyspnoea—Methotrexate—hematologic cancer	5.49e-05	0.000168	CcSEcCtD
Hydrocodone—Somnolence—Methotrexate—hematologic cancer	5.48e-05	0.000167	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—hematologic cancer	5.44e-05	0.000166	CcSEcCtD
Hydrocodone—Hypersensitivity—Prednisone—hematologic cancer	5.43e-05	0.000166	CcSEcCtD
Hydrocodone—Hypotension—Epirubicin—hematologic cancer	5.39e-05	0.000165	CcSEcCtD
Hydrocodone—Vomiting—Dexamethasone—hematologic cancer	5.38e-05	0.000164	CcSEcCtD
Hydrocodone—Vomiting—Betamethasone—hematologic cancer	5.38e-05	0.000164	CcSEcCtD
Hydrocodone—Rash—Dexamethasone—hematologic cancer	5.34e-05	0.000163	CcSEcCtD
Hydrocodone—Rash—Betamethasone—hematologic cancer	5.34e-05	0.000163	CcSEcCtD
Hydrocodone—Dermatitis—Dexamethasone—hematologic cancer	5.33e-05	0.000163	CcSEcCtD
Hydrocodone—Dermatitis—Betamethasone—hematologic cancer	5.33e-05	0.000163	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.32e-05	0.000163	CcSEcCtD
Hydrocodone—Fatigue—Methotrexate—hematologic cancer	5.31e-05	0.000162	CcSEcCtD
Hydrocodone—Headache—Dexamethasone—hematologic cancer	5.3e-05	0.000162	CcSEcCtD
Hydrocodone—Headache—Betamethasone—hematologic cancer	5.3e-05	0.000162	CcSEcCtD
Hydrocodone—Asthenia—Prednisone—hematologic cancer	5.29e-05	0.000162	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.25e-05	0.000161	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—hematologic cancer	5.23e-05	0.00016	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—hematologic cancer	5.22e-05	0.00016	CcSEcCtD
Hydrocodone—Pruritus—Prednisone—hematologic cancer	5.22e-05	0.000159	CcSEcCtD
Hydrocodone—Insomnia—Epirubicin—hematologic cancer	5.22e-05	0.000159	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—hematologic cancer	5.18e-05	0.000158	CcSEcCtD
Hydrocodone—Paraesthesia—Epirubicin—hematologic cancer	5.18e-05	0.000158	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—hematologic cancer	5.16e-05	0.000158	CcSEcCtD
Hydrocodone—Dyspnoea—Epirubicin—hematologic cancer	5.14e-05	0.000157	CcSEcCtD
Hydrocodone—Somnolence—Epirubicin—hematologic cancer	5.13e-05	0.000157	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Methotrexate—hematologic cancer	5.04e-05	0.000154	CcSEcCtD
Hydrocodone—Nausea—Dexamethasone—hematologic cancer	5.03e-05	0.000154	CcSEcCtD
Hydrocodone—Nausea—Betamethasone—hematologic cancer	5.03e-05	0.000154	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—hematologic cancer	4.99e-05	0.000152	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.98e-05	0.000152	CcSEcCtD
Hydrocodone—Fatigue—Epirubicin—hematologic cancer	4.97e-05	0.000152	CcSEcCtD
Hydrocodone—Constipation—Epirubicin—hematologic cancer	4.93e-05	0.000151	CcSEcCtD
Hydrocodone—Dizziness—Prednisone—hematologic cancer	4.88e-05	0.000149	CcSEcCtD
Hydrocodone—Abdominal pain—Methotrexate—hematologic cancer	4.87e-05	0.000149	CcSEcCtD
Hydrocodone—Body temperature increased—Methotrexate—hematologic cancer	4.87e-05	0.000149	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.86e-05	0.000149	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—hematologic cancer	4.83e-05	0.000147	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—hematologic cancer	4.79e-05	0.000146	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—hematologic cancer	4.76e-05	0.000145	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—hematologic cancer	4.74e-05	0.000145	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Epirubicin—hematologic cancer	4.72e-05	0.000144	CcSEcCtD
Hydrocodone—Vomiting—Prednisone—hematologic cancer	4.69e-05	0.000143	CcSEcCtD
Hydrocodone—Rash—Prednisone—hematologic cancer	4.65e-05	0.000142	CcSEcCtD
Hydrocodone—Dermatitis—Prednisone—hematologic cancer	4.64e-05	0.000142	CcSEcCtD
Hydrocodone—Headache—Prednisone—hematologic cancer	4.62e-05	0.000141	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.61e-05	0.000141	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—hematologic cancer	4.6e-05	0.000141	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—hematologic cancer	4.56e-05	0.000139	CcSEcCtD
Hydrocodone—Abdominal pain—Epirubicin—hematologic cancer	4.56e-05	0.000139	CcSEcCtD
Hydrocodone—Body temperature increased—Epirubicin—hematologic cancer	4.56e-05	0.000139	CcSEcCtD
Hydrocodone—Hypersensitivity—Methotrexate—hematologic cancer	4.54e-05	0.000139	CcSEcCtD
Hydrocodone—Asthenia—Methotrexate—hematologic cancer	4.42e-05	0.000135	CcSEcCtD
Hydrocodone—Nausea—Prednisone—hematologic cancer	4.38e-05	0.000134	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.36e-05	0.000133	CcSEcCtD
Hydrocodone—Pruritus—Methotrexate—hematologic cancer	4.36e-05	0.000133	CcSEcCtD
Hydrocodone—Hypersensitivity—Epirubicin—hematologic cancer	4.25e-05	0.00013	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—hematologic cancer	4.22e-05	0.000129	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—hematologic cancer	4.22e-05	0.000129	CcSEcCtD
Hydrocodone—Asthenia—Epirubicin—hematologic cancer	4.14e-05	0.000126	CcSEcCtD
Hydrocodone—Pruritus—Epirubicin—hematologic cancer	4.08e-05	0.000125	CcSEcCtD
Hydrocodone—Dizziness—Methotrexate—hematologic cancer	4.08e-05	0.000124	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—hematologic cancer	3.93e-05	0.00012	CcSEcCtD
Hydrocodone—Vomiting—Methotrexate—hematologic cancer	3.92e-05	0.00012	CcSEcCtD
Hydrocodone—Rash—Methotrexate—hematologic cancer	3.89e-05	0.000119	CcSEcCtD
Hydrocodone—Dermatitis—Methotrexate—hematologic cancer	3.88e-05	0.000119	CcSEcCtD
Hydrocodone—Headache—Methotrexate—hematologic cancer	3.86e-05	0.000118	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—hematologic cancer	3.83e-05	0.000117	CcSEcCtD
Hydrocodone—Dizziness—Epirubicin—hematologic cancer	3.81e-05	0.000117	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—hematologic cancer	3.78e-05	0.000115	CcSEcCtD
Hydrocodone—Vomiting—Epirubicin—hematologic cancer	3.67e-05	0.000112	CcSEcCtD
Hydrocodone—Nausea—Methotrexate—hematologic cancer	3.66e-05	0.000112	CcSEcCtD
Hydrocodone—Rash—Epirubicin—hematologic cancer	3.64e-05	0.000111	CcSEcCtD
Hydrocodone—Dermatitis—Epirubicin—hematologic cancer	3.63e-05	0.000111	CcSEcCtD
Hydrocodone—Headache—Epirubicin—hematologic cancer	3.61e-05	0.00011	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—hematologic cancer	3.53e-05	0.000108	CcSEcCtD
Hydrocodone—Nausea—Epirubicin—hematologic cancer	3.43e-05	0.000105	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—hematologic cancer	3.39e-05	0.000104	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—hematologic cancer	3.36e-05	0.000103	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—hematologic cancer	3.36e-05	0.000103	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—hematologic cancer	3.34e-05	0.000102	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—hematologic cancer	3.17e-05	9.68e-05	CcSEcCtD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CG—hematologic cancer	1.28e-05	0.00017	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KIT—hematologic cancer	1.28e-05	0.00017	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—NRAS—hematologic cancer	1.28e-05	0.00017	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	1.28e-05	0.00017	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TSC2—hematologic cancer	1.27e-05	0.000169	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTAP—hematologic cancer	1.27e-05	0.000169	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGF1—hematologic cancer	1.27e-05	0.000168	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CSF2—hematologic cancer	1.27e-05	0.000168	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTPN11—hematologic cancer	1.26e-05	0.000167	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.25e-05	0.000167	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.25e-05	0.000167	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	1.25e-05	0.000166	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	1.25e-05	0.000166	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	1.24e-05	0.000165	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	1.23e-05	0.000164	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—MAPK3—hematologic cancer	1.23e-05	0.000163	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	1.23e-05	0.000163	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGFR3—hematologic cancer	1.22e-05	0.000163	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JAK1—hematologic cancer	1.22e-05	0.000162	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	1.22e-05	0.000162	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.22e-05	0.000162	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CREB1—hematologic cancer	1.22e-05	0.000162	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK14—hematologic cancer	1.21e-05	0.000161	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—BRAF—hematologic cancer	1.21e-05	0.00016	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL2—hematologic cancer	1.19e-05	0.000159	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6R—hematologic cancer	1.19e-05	0.000158	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ESR1—hematologic cancer	1.19e-05	0.000158	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CREBBP—hematologic cancer	1.19e-05	0.000158	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NUP98—hematologic cancer	1.18e-05	0.000157	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FN1—hematologic cancer	1.17e-05	0.000156	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—BAD—hematologic cancer	1.16e-05	0.000154	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NFKBIA—hematologic cancer	1.16e-05	0.000154	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOTCH1—hematologic cancer	1.15e-05	0.000153	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.15e-05	0.000153	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.15e-05	0.000153	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	1.14e-05	0.000152	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NUP214—hematologic cancer	1.14e-05	0.000152	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAP2K1—hematologic cancer	1.13e-05	0.000151	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—FHL2—hematologic cancer	1.13e-05	0.000151	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL2—hematologic cancer	1.13e-05	0.00015	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TERT—hematologic cancer	1.13e-05	0.00015	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CD—hematologic cancer	1.13e-05	0.00015	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CD80—hematologic cancer	1.13e-05	0.00015	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CG—hematologic cancer	1.12e-05	0.000149	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KIT—hematologic cancer	1.12e-05	0.000149	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—NRAS—hematologic cancer	1.12e-05	0.000149	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTR—hematologic cancer	1.12e-05	0.000148	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.12e-05	0.000148	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.12e-05	0.000148	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AGRN—hematologic cancer	1.11e-05	0.000148	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	1.1e-05	0.000147	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—KRAS—hematologic cancer	1.1e-05	0.000147	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	1.1e-05	0.000146	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ENO2—hematologic cancer	1.09e-05	0.000146	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FGF2—hematologic cancer	1.08e-05	0.000143	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	1.08e-05	0.000143	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TSC2—hematologic cancer	1.08e-05	0.000143	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CREB1—hematologic cancer	1.07e-05	0.000142	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	1.06e-05	0.000141	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.06e-05	0.000141	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—BRAF—hematologic cancer	1.06e-05	0.00014	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—IDH2—hematologic cancer	1.05e-05	0.00014	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMMR—hematologic cancer	1.05e-05	0.00014	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL2—hematologic cancer	1.05e-05	0.000139	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6R—hematologic cancer	1.04e-05	0.000139	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	1.04e-05	0.000139	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SDC1—hematologic cancer	1.04e-05	0.000138	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	1.03e-05	0.000138	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—JAK2—hematologic cancer	1.03e-05	0.000138	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	1.02e-05	0.000136	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	1.01e-05	0.000135	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MDM2—hematologic cancer	1.01e-05	0.000134	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ESR1—hematologic cancer	1.01e-05	0.000134	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	9.95e-06	0.000132	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FN1—hematologic cancer	9.93e-06	0.000132	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ARNTL—hematologic cancer	9.9e-06	0.000132	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	9.88e-06	0.000131	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	9.82e-06	0.000131	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MTOR—hematologic cancer	9.82e-06	0.000131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	9.81e-06	0.00013	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—BAD—hematologic cancer	9.81e-06	0.00013	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	9.79e-06	0.00013	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	9.72e-06	0.000129	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	9.68e-06	0.000129	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CA9—hematologic cancer	9.63e-06	0.000128	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ACP5—hematologic cancer	9.63e-06	0.000128	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CD80—hematologic cancer	9.52e-06	0.000127	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOR2—hematologic cancer	9.51e-06	0.000126	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KIT—hematologic cancer	9.5e-06	0.000126	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	9.5e-06	0.000126	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	9.5e-06	0.000126	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGF2—hematologic cancer	9.46e-06	0.000126	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	9.38e-06	0.000125	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	9.33e-06	0.000124	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	9.33e-06	0.000124	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	9.22e-06	0.000123	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	9.12e-06	0.000121	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	9.1e-06	0.000121	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—JAK2—hematologic cancer	9.07e-06	0.000121	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—IDH1—hematologic cancer	9.06e-06	0.00012	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CREB1—hematologic cancer	9.04e-06	0.00012	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CASP3—hematologic cancer	9.04e-06	0.00012	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL2—hematologic cancer	9.02e-06	0.00012	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—hematologic cancer	8.98e-06	0.000119	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.95e-06	0.000119	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.95e-06	0.000119	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TXN—hematologic cancer	8.95e-06	0.000119	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—BRAF—hematologic cancer	8.93e-06	0.000119	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	8.89e-06	0.000118	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MDM2—hematologic cancer	8.85e-06	0.000118	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL2—hematologic cancer	8.85e-06	0.000118	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CD44—hematologic cancer	8.83e-06	0.000117	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NQO1—hematologic cancer	8.83e-06	0.000117	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6R—hematologic cancer	8.82e-06	0.000117	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	8.81e-06	0.000117	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCND1—hematologic cancer	8.79e-06	0.000117	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—JUN—hematologic cancer	8.78e-06	0.000117	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SPHK1—hematologic cancer	8.76e-06	0.000117	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MTOR—hematologic cancer	8.61e-06	0.000115	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	8.61e-06	0.000115	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	8.51e-06	0.000113	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTEN—hematologic cancer	8.49e-06	0.000113	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	8.42e-06	0.000112	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	8.41e-06	0.000112	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	8.35e-06	0.000111	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYCS—hematologic cancer	8.35e-06	0.000111	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	8.3e-06	0.00011	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	8.3e-06	0.00011	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	8.28e-06	0.00011	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	8.27e-06	0.00011	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	8.22e-06	0.000109	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	8.19e-06	0.000109	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CRABP1—hematologic cancer	8.19e-06	0.000109	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	8.18e-06	0.000109	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EP300—hematologic cancer	8.1e-06	0.000108	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	8.08e-06	0.000107	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGF2—hematologic cancer	8e-06	0.000106	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	8e-06	0.000106	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.98e-06	0.000106	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CASP3—hematologic cancer	7.92e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL2—hematologic cancer	7.91e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	7.89e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SRC—hematologic cancer	7.87e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—hematologic cancer	7.87e-06	0.000105	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NUP98—hematologic cancer	7.73e-06	0.000103	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCND1—hematologic cancer	7.71e-06	0.000103	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—JUN—hematologic cancer	7.7e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	7.67e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JAK2—hematologic cancer	7.67e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT3—hematologic cancer	7.59e-06	0.000101	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NRAS—hematologic cancer	7.57e-06	0.000101	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	7.51e-06	9.99e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ADCY7—hematologic cancer	7.5e-06	9.98e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOA3—hematologic cancer	7.5e-06	9.98e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MDM2—hematologic cancer	7.48e-06	9.95e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	7.46e-06	9.92e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NUP214—hematologic cancer	7.45e-06	9.91e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTEN—hematologic cancer	7.44e-06	9.9e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTP1—hematologic cancer	7.36e-06	9.79e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCG2—hematologic cancer	7.3e-06	9.71e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTR—hematologic cancer	7.3e-06	9.71e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	7.28e-06	9.68e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	7.28e-06	9.68e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MTOR—hematologic cancer	7.28e-06	9.68e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	7.26e-06	9.65e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	7.25e-06	9.64e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ENO2—hematologic cancer	7.16e-06	9.52e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EP300—hematologic cancer	7.1e-06	9.44e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MYC—hematologic cancer	7.05e-06	9.38e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	7.04e-06	9.36e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCB1—hematologic cancer	6.97e-06	9.26e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	6.95e-06	9.24e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.94e-06	9.23e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SRC—hematologic cancer	6.9e-06	9.18e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	6.83e-06	9.08e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SDC1—hematologic cancer	6.79e-06	9.02e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NCOR1—hematologic cancer	6.76e-06	8.99e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTM1—hematologic cancer	6.76e-06	8.99e-05	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	6.76e-06	8.99e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	6.72e-06	8.94e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CASP3—hematologic cancer	6.7e-06	8.9e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2—hematologic cancer	6.69e-06	8.89e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT3—hematologic cancer	6.66e-06	8.85e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—hematologic cancer	6.65e-06	8.84e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NRAS—hematologic cancer	6.64e-06	8.83e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KRAS—hematologic cancer	6.52e-06	8.67e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCND1—hematologic cancer	6.52e-06	8.67e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JUN—hematologic cancer	6.5e-06	8.65e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	6.36e-06	8.46e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	6.31e-06	8.38e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTEN—hematologic cancer	6.29e-06	8.36e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MYC—hematologic cancer	6.19e-06	8.22e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	6.17e-06	8.2e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	6.15e-06	8.18e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	6.14e-06	8.16e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EP300—hematologic cancer	6e-06	7.98e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	5.99e-06	7.96e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—hematologic cancer	5.98e-06	7.95e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SRC—hematologic cancer	5.83e-06	7.76e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TP53—hematologic cancer	5.79e-06	7.7e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CD44—hematologic cancer	5.77e-06	7.67e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NQO1—hematologic cancer	5.77e-06	7.67e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KRAS—hematologic cancer	5.72e-06	7.6e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	5.68e-06	7.55e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT3—hematologic cancer	5.63e-06	7.48e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NRAS—hematologic cancer	5.61e-06	7.46e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HRAS—hematologic cancer	5.54e-06	7.37e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYCS—hematologic cancer	5.46e-06	7.26e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	5.43e-06	7.21e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	5.38e-06	7.15e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—hematologic cancer	5.3e-06	7.05e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	5.25e-06	6.98e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MYC—hematologic cancer	5.23e-06	6.95e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	5.22e-06	6.93e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TP53—hematologic cancer	5.08e-06	6.75e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	5.02e-06	6.68e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT1—hematologic cancer	4.89e-06	6.5e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HRAS—hematologic cancer	4.86e-06	6.46e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KRAS—hematologic cancer	4.83e-06	6.42e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.81e-06	6.4e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CREBBP—hematologic cancer	4.66e-06	6.19e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—hematologic cancer	4.65e-06	6.18e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.56e-06	6.06e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	4.44e-06	5.9e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.42e-06	5.88e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.42e-06	5.88e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	4.42e-06	5.87e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—hematologic cancer	4.36e-06	5.8e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TP53—hematologic cancer	4.29e-06	5.71e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT1—hematologic cancer	4.29e-06	5.7e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	4.17e-06	5.54e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HRAS—hematologic cancer	4.11e-06	5.46e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—hematologic cancer	3.93e-06	5.22e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.91e-06	5.2e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.85e-06	5.12e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT1—hematologic cancer	3.63e-06	4.82e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTEN—hematologic cancer	3.33e-06	4.42e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.28e-06	4.37e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—EP300—hematologic cancer	3.17e-06	4.22e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.04e-06	4.05e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.89e-06	3.84e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—hematologic cancer	2.85e-06	3.79e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.73e-06	3.62e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.52e-06	3.35e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.35e-06	3.12e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTEN—hematologic cancer	2.17e-06	2.89e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—EP300—hematologic cancer	2.07e-06	2.76e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKT1—hematologic cancer	1.92e-06	2.55e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.53e-06	2.04e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKT1—hematologic cancer	1.25e-06	1.67e-05	CbGpPWpGaD
